MedTrace Logo

Barrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype

NCT06532734 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2025-12-10

No results posted yet for this study

Summary

To better define the presence of Barrett's esophagus (BE) via non-endoscopic testing in an eating disorder cohort with purging (vomiting/rumination) behaviors

Conditions

  • Barrett Esophagus
  • Anorexia Nervosa, Binge Eating/Purging Type
  • Rumination
  • Vomiting
  • Eating Disorders
  • Esophageal Adenocarcinoma

Interventions

DEVICE

EsoGuard

device used to collect esophageal cell samples to test for the presence of abnormal cells which may indicate a dx of Barrett's esophagitis.

Sponsors & Collaborators

  • Lucid Diagnostics, Inc.

    collaborator INDUSTRY

  • Denver Health and Hospital Authority

    lead OTHER

Principal Investigators

  • Allison Nitsch, MD · Denver Health and Hospital Authority

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-12
Primary Completion
2026-11-30
Completion
2026-11-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06532734 on ClinicalTrials.gov